Keywords: zeneca, pursue, mth, zestril, exclusivity, pharmaceuticals, pursuing
Zeneca to Pursue 6 mth Zestril exclusivity in US
Article | 07 January 1999
- Zeneca Pharmaceuticals is pursuing a six-month extension of USmarketing exclusivity for Zestril (lisinopril). It has received a request from the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
